Vikram Rao, MD
Vascular Surgery · Willoughby, OHNPI 1881637825
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.9%), consulting fees and other — rather than concentrated in one kind of arrangement. 49 manufacturers reported payments, led by Abbott at 24.2% of the total. Among vascular surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 935 payments — averaging $146.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$33K
- Medtronic$30K
- Convatec Inc.$22K
- Boston Scientific$14K
- Penumbra, Inc.$12K
- Endologix LLC$8K
- plus $18K from 43 others
Across 50 payments — averaging $1682.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$42K
- Endologix LLC$42K
Across 5 payments — averaging $2617.38 each. An ownership or investment interest held by the physician or an immediate family member.
- Centerline Biomedical Inc.$13K
What the payments were for
- Consulting fees$31,93723%
- Speaking & faculty fees$17,40013%
- Travel & lodging$6,8365%
- Food & beverage$58,93043%
- Education$1270%
- Other$22,09316%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$22,093
- Indigo$7,494
- IN.PACT Admiral$6,820
- Perclose ProGlide suture mediated closure system$5,995
- Supera peripheral stent system$5,887
- Emboshield NAV6 system$5,843
- Omnilink Elite vascular stent system$4,745
- Xience V coronary stent system$4,563
- GENERAL - THERAPIES$4,491
- SURGICEL NU-KNIT$3,865
- VISTASEAL$3,865
- Alto Abdominal Stent Graft System$2,613
- Penumbra Ruby Coil$2,500
- AFX$2,100
- HawkOne$2,018
- NA$1,915
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,721
- ENDURANT IIS$1,171
- TREO ABDOMINAL STENT-GRAFT SYSTEM$1,024
- Absolute Pro vascular stent system$763
How this compares
$137,323 in reported general payments places this provider in the 95th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $21,091 |
| XareltoRivaroxaban | 11 | $8,117 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,304 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $103 | $21,09123 claims |
| Johnson & JohnsonXarelto | $4,236 | $8,11711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 213 vascular surgery providers in Ohio.
Other vascular surgery in Willoughby
- Patrick MuckCincinnati$650K
- Sean LydenCleveland$561K
- Brian KuhnCincinnati$184K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
- Matthew RechtCincinnati$73K
- Geoffrey AnswiniCincinnati$65K
- John PigottToledo$65K
- Adam ReichardMontgomery$62K
- John FishToledo$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.